| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442029 | European Journal of Cancer | 2015 | 16 Pages |
Abstract
This is the first rigorous pooled analysis assessing miRNAs as prognostic biomarkers in PDAC. Tumoural miR-21 overexpression emerged as an important predictor of poor prognosis after PDAC resection independent of other clinicopathologic factors, including adjuvant chemotherapy use.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Adam E. Frampton, Jonathan Krell, Nigel B. Jamieson, Tamara M.H. Gall, Elisa Giovannetti, Niccola Funel, Mireia Mato Prado, Daniel Krell, Nagy A. Habib, Leandro Castellano, Long R. Jiao, Justin Stebbing,